Reproductive Medicine – When Do Breakthrough Technologies Become Standards of Care?
- Sep 14, 2018 6:58 pm
© 2018, GENASSIST, Inc. By Keith S. Wexler, MBA, CFO, Business Development Director, GENASSIST, Inc. Paul Wexler, M.D., F.A.C.O.G., Medical Director, GENASSIST, Inc. Clinical Professor, Department of OB/GYN, University of Colorado Health Sciences Center Clinical Professor, Division of Genetics/Dept. of Pediatrics, Univ. of Colorado/The Children’s Hospital Background: Since November 2017, insurance companies have started to […]
Read more ...